SCHEMBL4629510

SCHEMBL4629510

Cc1cccc(C)c1Cc1c[nH]cn1.c1ccc(Cc2c[nH]cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.40
▸ POLB P06746 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ AR P10275 1/20 0.35
▸ IDH1 O75874 1/20 0.34
▸ MET P08581 1/20 0.34
▸ ENPP1 P22413 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ ALKBH3 Q96Q83 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2103783 0.91 TAAR1 (0.46) TAAR1POLBALDH1A1HTR1DAR
SCHEMBL4628344 0.85 GABRA1 (0.35) TAAR1POLBALDH1A1GABRA1GABRB2
SCHEMBL649075 0.85 ALDH1A1 (0.46) TAAR1POLBALDH1A1METSMN1; SMN2
SCHEMBL4628180 0.80 TAAR1 (0.36) TAAR1ALDH1A1HTR1DARHPGD
SCHEMBL2102247 0.79 TAAR1 (0.41) TAAR1HTR1DARGABRA1GABRB2
SCHEMBL6967970 0.76 ALDH1A1 (0.39) TAAR1ALDH1A1METSMN1; SMN2TLR8
SCHEMBL11045854 0.76 DAO (0.42) TAAR1HPGD
SCHEMBL4629511 0.76 TAAR1 (0.40) TAAR1POLBALDH1A1HTR1DAR
SCHEMBL2103250 0.76 TSHR (0.41) ALDH1A1HPGDRAB9AKDM4EHSD17B10
SCHEMBL6972728 0.76 ALDH1A1 (0.42) TAAR1ALDH1A1ARSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 — — EP claimed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 — — WO claimed
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 — — EP disclosed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 — — WO disclosed
Send feedback